Improving risk stratification in acute pulmonary embolism: How do we target our therapies more effectively?

Vasc Med

Department of Medicine, Division of Cardiology, Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, NY, USA.

Published: October 2021

Download full-text PDF

Source
http://dx.doi.org/10.1177/1358863X211021917DOI Listing

Publication Analysis

Top Keywords

improving risk
4
risk stratification
4
stratification acute
4
acute pulmonary
4
pulmonary embolism
4
embolism target
4
target therapies
4
therapies effectively?
4
improving
1
stratification
1

Similar Publications

Utility and bias in psychosocial evaluations for transplant listing.

Curr Opin Organ Transplant

January 2025

Department of Community Health.

Purpose Of Review: Disparities in access to transplantation are persistent and pervasive among minoritized populations, and remain incompletely explained by socioeconomic status, insurance, geography, or medical factors. Although much attention has been paid to factors contributing to disparities in organ allocation, fewer studies have focused on barriers to the transplant waitlist. Given increasing calls for equity in organ transplantation, we examine the role of nonmedical factors used in transplant listing decisions, including psychosocial factors like social support, motivation, and knowledge in improving utility in transplant listing decisions, as well as their potential for reinforcing bias.

View Article and Find Full Text PDF

Purpose Of Review: Demonstrate the impact of allocation system design on access to the waitlist and transplantation for patients with end-stage kidney disease (ESKD).

Recent Findings: Minoritized groups are more likely to be declined from transplant listing owing to psychosocial criteria. Lack of consistent definitions, screening tools with differential subgroup validity, and insufficient evidence-base contribute to concerns about reliance on psychosocial factors in transplant listing decisions.

View Article and Find Full Text PDF

Background And Aims: Vedolizumab is s gut-selective advanced therapy that is safe and efficacious for the treatment of ulcerative colitis (UC). Once patients achieve successful induction, there is a risk of loss of response leading to eventual flare. We aimed to identify these predictive factors and develop a practical scoring system to determine the ongoing efficacy of vedolizumab.

View Article and Find Full Text PDF

Background/aims: Active inflammatory bowel disease (IBD) increases the risk of pregnancy complications and contraceptive side effects, and contraceptive use may impact the clinical course of IBD. Although young people are at elevated risk for unintended pregnancy, those with IBD receive minimal disease-specific contraceptive guidance. We characterized perspectives and preferences on contraception and reproductive health counseling from young women with IBD.

View Article and Find Full Text PDF

Chronic kidney disease (CKD) is expected to become the fifth leading cause of death globally by 2040. Cardiovascular disease (CVD), particularly heart failure (HF), is a severe complication in CKD patients on hemodialysis. This study aimed to develop a nomogram to predict the risk of heart failure hospitalization in hemodialysis patients, providing a valuable tool for clinical decision-making.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!